US Stock MarketDetailed Quotes

EXFY Expensify

Watchlist

3.600
+0.100+2.86%

Close Jan 3 16:00 ET

3.940
+0.340+9.44%

Post 20:01 ET

320.27MMarket Cap-20.00P/E (TTM)

Expensify Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Expensify Q3 2024 Earnings Date

Currency：USDNov 7, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	34.62M	35.41M	+792.25K
Beat Est.	-5.14%	-2.97%	+2.29%
EPS	-0.04	-0.02	+0.02
Beat Est.	+78.61%	+90.48%	+55.46%

Analyst Rating

Buy

Jan 4, 2025

Expensify Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 36.227M	--
--	2024/Q4	-- / 36.030M	--
Nov 7, 2024	2024/Q3	35.409M / 34.617M	--
Aug 8, 2024	2024/Q2	33.288M / 34.569M	--
May 9, 2024	2024/Q1	33.535M / 34.623M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 36.227M--

--2024/Q4-- / 36.030M--

Nov 7, 20242024/Q335.409M / 34.617M--

Aug 8, 20242024/Q233.288M / 34.569M--

May 9, 20242024/Q133.535M / 34.623M--

Unlock Free Earnings Estimates

Open Account

Expensify Earnings Reports

Expensify | 10-Q: Q3 2024 Earnings Report

Nov 8, 2024 16:06 ET

Expensify | 10-Q: Q2 2024 Earnings Report

Aug 9, 2024 13:55 ET

Expensify | 10-Q: Q1 2024 Earnings Report

May 9, 2024 16:22 ET

Expensify | 10-K: FY2023 Annual Report

Feb 27, 2024 06:10 ET

Trending US Stocks

Symbol Mini Chart % Chg

DexCom

DXCM

+3.27%

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Jan 4, 2025

Buy

Buy
66.67%
Hold
33.33%
Sell
0.00%

Price Target

No Data